Tissue Transglutaminase Immunoglobulin Isotypes in Children With Untreated and Treated Celiac Disease

Abstract

ABSTRACTObjectivesTissue transglutaminase (tTG) autoantibodies are serologic markers for celiac disease (CD). The aim was to determine the diagnostic sensitivity and specificity of different immunoglobulin isotypes against tTG.MethodsImmunoglobulin A (IgA)‐tTG, IgG‐tTG, and IgG1‐tTG were measured in radioligand binding assays in 67 children with untreated and 89 children with treated CD and compared with 48 biopsy controls. IgM‐tTG was measured in children with untreated CD and in biopsy controls. IgA endomysial autoantibodies (EMA) were analyzed in all children using an immunofluorescence method.ResultsThe sensitivity of IgA‐tTG and IgG‐tTG was 85.1% (57 of 67) and 83.6% (56 of 67), respectively, which both increased to 93.8% (45 of 48) in children diagnosed at age 2 years or older. Both had a specificity of 93.8% (45 of 48). IgA‐EMA had a sensitivity of 80.6% (54 of 67) and a specificity of 91.7% (44 of 48). In treated CD, IgA‐tTG and IgG‐tTG were detected in 21.3% (19 of 89) and in 14.6% (13 of 89), respectively, despite negative EMA titers. IgG1‐tTG was correlated to age (r = −0.47, P = 0.0005) and detected in 50.7% (34 of 67) with untreated CD compared with 11.2% (10 of 89) with treated CD and with 4.2% (2 of 48) of biopsy controls (P < 0.0001, respectively). IgM‐tTG was detected in 1.5% (1 of 67) with untreated CD and in none of biopsy controls.ConclusionIgA‐tTG and IgG‐tTG analyzed in radioligand binding assays are equivalent to IgA‐EMA as screening tests for CD during childhood, but an intestinal biopsy is still the method of choice to establish the diagnosis. Although IgG1‐tTG was more common at young age of diagnosis, both IgG1‐tTG and IgM‐tTG had low specificity and sensitivity and may not be useful as screening tests for CD.